SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-056413
Filing Date
2015-06-25
Accepted
2015-06-25 17:38:44
Documents
2
Period of Report
2015-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2788
2 EX-24 DOCUMENT attachment1.htm EX-24 4277
  Complete submission text file 0001209191-15-056413.txt   8536
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES HEALTH, INC. 161 FIRST STREET CAMBRIDGE MA 02472
Business Address
Kim Lorence H. (Reporting) CIK: 0001643746 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 15952607